International Clinical Trial: A bio-equivalence study of a randomized, open label, 4-period, 2-treatment, 2-sequence, fully replicate, crossover study of EPA NIKP Soft Cap 900 mg relative to EPADEL S900 (Original Ethyl Icosapentate 900 mg) in healthy Thai participants under fed condition

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (TCTR20260405008) titled 'A bio-equivalence study of a randomized, open label, 4-period, 2-treatment, 2-sequence, fully replicate, crossover study of EPA NIKP Soft Cap 900 mg relative to EPADEL S900 (Original Ethyl Icosapentate 900 mg) in healthy Thai participants under fed condition' on April 5.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Bio-innova Co., Ltd.

Condition: Healthy volunteers Bioequivalence EPA NIKP Soft Cap 900 mg Bioequivalence EPA NIKP Soft Cap 900 mg

Intervention: The new generic products which were recently developed. Volunteer will receive a single dose of EPA NIKP Soft Cap 900 mg with ...